Compound ID | 2630
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus |
| Description: | Natural product from Actinosporangium sp.; also shows anti-tumour properties in mice; an anthracycline |
| Institute where first reported: | Research Division, Bristol Laboratories, Division of Bristol Myers Company, Syracuse, N. Y., U. S. A |
| Year first mentioned: | 1977 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/107861 |
| Citations: |
|
| Patent: | US4064014A |